Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70851 - 70875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	GYG2	8908	downregulated	Silicon Dioxide analog results in decreased expression of GYG2 mRNA	Xp22.33	A24195
Silicon dioxide	Approved	H19	283120	downregulated	Silicon Dioxide analog results in decreased expression of H19 mRNA	11p15.5	A24195
Silicon dioxide	Approved	H2AFJ	55766	upregulated	Silicon Dioxide analog results in increased expression of H2AFJ mRNA	12p12.3	A24194
Silicon dioxide	Approved	H2AFX	3014	upregulated	Silicon Dioxide results in increased expression of H2AFX mRNA	11q23.3	A24196
Silicon dioxide	Approved	H3F3B	3021	upregulated	Silicon Dioxide results in increased expression of H3F3B mRNA	17q25.1	A24196
Silicon dioxide	Approved	H6PD	9563	downregulated	Silicon Dioxide analog results in decreased expression of H6PD mRNA	1p36.22	A24195
Silicon dioxide	Approved	H6PD	9563	downregulated	Silicon Dioxide results in decreased expression of H6PD mRNA	1p36.22	A24196
Silicon dioxide	Approved	HABP2	3026	downregulated	Silicon Dioxide analog results in decreased expression of HABP2 mRNA	10q25.3	A24195
Silicon dioxide	Approved	HACD4	401494	downregulated	Silicon Dioxide analog results in decreased expression of HACD4 mRNA	9p21.3	A24195
Silicon dioxide	Approved	HAGH	3029	downregulated	Silicon Dioxide results in decreased expression of HAGH mRNA	16p13.3	A24209
Silicon dioxide	Approved	HAGLR	401022	upregulated	Silicon Dioxide analog results in increased expression of HAGLR mRNA	2q31.1	A24194
Silicon dioxide	Approved	HAO1	54363	downregulated	Silicon Dioxide analog results in decreased expression of HAO1 mRNA	20p12.3	A24195
Silicon dioxide	Approved	HAS3	3038	upregulated	Silicon Dioxide analog results in increased expression of HAS3 mRNA	16q22.1	A24195
Silicon dioxide	Approved	HAUS7	55559	upregulated	Silicon Dioxide results in increased expression of HAUS7 mRNA	Xq28	A24196
Silicon dioxide	Approved	HAVCR2	84868	downregulated	Silicon Dioxide analog results in decreased expression of HAVCR2 mRNA	5q33.3	A24194
Silicon dioxide	Approved	HAVCR2	84868	upregulated	Silicon Dioxide analog results in increased expression of HAVCR2 mRNA	5q33.3	A24195
Silicon dioxide	Approved	HBB	3043	downregulated	Silicon Dioxide analog results in decreased expression of HBB mRNA	11p15.4	A24195
Silicon dioxide	Approved	HBD	3045	downregulated	Silicon Dioxide analog results in decreased expression of HBD mRNA	11p15.4	A24195
Silicon dioxide	Approved	HBEGF	1839	upregulated	Silicon Dioxide analog results in increased expression of HBEGF mRNA	5q31.3	A24195
Silicon dioxide	Approved	HBP1	26959	downregulated	Silicon Dioxide analog results in decreased expression of HBP1 mRNA	7q22.3	A24195
Silicon dioxide	Approved	HCAR2	338442	upregulated	Silicon Dioxide analog results in increased expression of HCAR2 mRNA	12q24.31	A24195
Silicon dioxide	Approved	HCAR3	8843	upregulated	Silicon Dioxide analog results in increased expression of HCAR3 mRNA	12q24.31	A24195
Silicon dioxide	Approved	HCAR3	8843	upregulated	Silicon Dioxide results in increased expression of HCAR3 mRNA	12q24.31	A24197 A24196
Silicon dioxide	Approved	HCP5	10866	upregulated	Silicon Dioxide results in increased expression of HCP5 mRNA	6p21.33	A24196
Silicon dioxide	Approved	HDAC5	10014	downregulated	Silicon Dioxide analog results in decreased expression of HDAC5 mRNA	17q21.31	A24195

Displaying entries 70851 - 70875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability